Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Dow
Medtronic
Harvard Business School
Baxter

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Drug Price Trends for IMATINIB MESYLATE

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for IMATINIB MESYLATE

Average Pharmacy Cost for IMATINIB MESYLATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
IMATINIB MESYLATE 400 MG TAB 72485-0203-30 7.55810 EACH 2019-10-30
IMATINIB MESYLATE 100 MG TAB 72485-0202-90 4.94632 EACH 2019-10-30
IMATINIB MESYLATE 400 MG TAB 00904-6621-04 7.55810 EACH 2019-10-23
IMATINIB MESYLATE 400 MG TAB 16714-0705-01 7.55810 EACH 2019-10-23
IMATINIB MESYLATE 400 MG TAB 00093-7630-56 7.55810 EACH 2019-10-23
IMATINIB MESYLATE 400 MG TAB 42292-0044-01 7.55810 EACH 2019-10-23
IMATINIB MESYLATE 400 MG TAB 00054-0249-13 7.55810 EACH 2019-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for IMATINIB MESYLATE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
IMATINIB MESYLATE 100MG TAB UD Major Pharmaceuticals 00904-6901-04 30 667.56 22.25200 EACH 2019-10-21 - 2023-11-30 FSS
IMATINIB MESYLATE 400MG TAB UD Major Pharmaceuticals 00904-6621-04 3X10 2798.66 2019-04-18 - 2023-11-30 FSS
IMATINIB MESYLATE 100MG TAB AvKare, Inc. 60505-2900-09 90 717.74 7.97489 EACH 2019-02-25 - 2022-12-31 FSS
IMATINIB MESYLATE 400MG TAB AvKare, Inc. 60505-2901-03 30 973.13 32.43767 EACH 2019-02-25 - 2022-12-31 FSS
GLEEVEC 100MG TAB Novartis Pharmaceuticals Corporation 00078-0401-34 90 6273.93 69.71033 EACH 2019-01-01 - 2020-03-31 Big4
GLEEVEC 100MG TAB Novartis Pharmaceuticals Corporation 00078-0401-34 90 8291.92 92.13244 EACH 2019-01-01 - 2020-03-31 FSS
GLEEVEC 400MG Novartis Pharmaceuticals Corporation 00078-0649-30 30 7526.24 250.87467 EACH 2019-01-01 - 2020-03-31 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Moodys
Dow
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.